MedPath

Proteomic Study of Plasma Exosomes in Patients With Diabetic Retinopathy

Not yet recruiting
Conditions
Diabetic Retinopathy
Registration Number
NCT06188013
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

Objective: Explore the biomarkers related to proliferative diabetic retinopathy by analyzing the protein expression profile changes of plasma exosomes in patients with difference phases of diabetic retinopathy, and investigate potential molecular mechanisms and therapeutic targets. Methods: Enrich exosomes from plasma by column extraction method. NTA, WB and TEM were used to characterize the obtained exosomes, and exosome proteinomics was performed by chromatography⁃mass spectrometry. Corhorts: The study was divided into four groups: a healthy control group, a diabetic without diabetic retinopathy group, a non-proliferative diabetic retinopathy group, and a proliferative diabetic retinopathy group, with 6 cases in each group.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Healthy volunteers without diabetes/ Senile cataract patients without diabetes;
  • Patients with diabetes who are diagnosed without DR, NPDR, and PDR by mydriatic fundus photography (or FFA);
Exclusion Criteria
  • Patients with systemic diseases such as cancer, immune diseases, infectious diseases, and blood diseases;
  • Patients with cerebral infarction, myocardial infarction and other cardiovascular and cerebrovascular diseases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
differential proteins of exosomesDecember,2023-June,2024

Exosomes were extracted and isolated from plasma, proteomics analysis of proteins in exosomes was performed to compare the number of types of changes in exosomal proteins of the four groups and to identify proteins that were up-regulated and/or down-regulated, and the relationship between the proteins and diabetic retinopathy was then analysed to look for possible mechanisms and therapeutic targets for diabetic retinopathy.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath